WDNA Performance — WisdomTree BioRevolution Fund
Data updated: 2026-09-14
WDNA returned +21.77% year to date and +59.85% over one year to Jun 2026. Annualised returns are +7.87% over 3 years and −3.81% over 5 years. Against its Health Care Equity category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $126, against $138 for the category, and to $160 over one year, against $137. Volatility over the past three years was 24.62% a year. In the 12 months to Jun 2026 the fund lost a net $358K, and assets reached $2.68M.
WDNA Growth of $100
What $100 invested in WisdomTree BioRevolution Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | WDNA | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $160 | $137 |
| 3 years (Jul 2023 – Jun 2026) | $126 | $138 |
| 5 years (Jul 2021 – Jun 2026) | $82 | $121 |
| Since data start (Jun 2021 – Jun 2026) | $88 | $127 |
WDNA Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +21.77% |
| 1 year | +59.85% |
| 3 years (annualised) | +7.87% |
| 5 years (annualised) | −3.81% |
WDNA Annual Returns
Calendar-year total returns of WisdomTree BioRevolution Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +21.77% |
| 2025 | +22.94% |
| 2024 | −14.15% |
| 2023 | −2.27% |
| 2022 | −26.06% |
| 2021 (Jun–Dec) | −5.58% |
WDNA Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +6.5% | +2.0% | −5.2% | +2.1% | +3.3% | +12.2% | — | — | — | — | — | — |
| 2025 | +5.1% | −7.1% | −8.7% | +2.9% | −7.1% | +9.9% | +2.6% | +3.4% | +11.9% | +7.5% | +1.5% | +1.4% |
| 2024 | −5.8% | +9.8% | −1.7% | −10.3% | +3.5% | −0.9% | +7.4% | −0.1% | −2.2% | −6.0% | +3.3% | −9.9% |
| 2023 | +5.1% | −5.9% | −0.2% | −0.5% | −0.4% | +2.4% | +5.6% | −9.6% | −9.0% | −9.8% | +11.4% | +11.9% |
| 2022 | −14.2% | −2.6% | +2.3% | −10.7% | −1.7% | −2.0% | +8.9% | −3.2% | −8.0% | +6.8% | +3.4% | −6.1% |
| 2021 | — | — | — | — | — | +6.5% | −2.9% | +5.2% | −6.4% | +0.1% | −6.2% | −1.1% |
WDNA Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 24.62%
- 3-year Sharpe ratio: 0.14 (vs 4.5% risk-free rate)
- Best month: +12.21% (Jun 2026)
- Worst month: −10.32% (Apr 2024)
WDNA Fund Flows
Monthly money in and out of WisdomTree BioRevolution Fund, from SEC Form N-PORT.
- 12-month net flow: −$358K
- 12-month gross sales (incl. reinvestments): $0
- Sales ÷ redemptions: 0.00×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $0 | $0 | $0 |
| May 2026 | $0 | $0 | $0 |
| Apr 2026 | $0 | $0 | $0 |
| Mar 2026 | $0 | $0 | $0 |
| Feb 2026 | $0 | $358K | −$358K |
| Jan 2026 | $0 | $0 | $0 |
| Dec 2025 | $0 | $0 | $0 |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $0 | $0 | $0 |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $0 | $0 | $0 |
| Jul 2025 | $0 | $0 | $0 |
WDNA Assets Under Management
Net assets of WisdomTree BioRevolution Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $2.68M |
| 2026-03-31 | $2.26M |
| 2025-12-31 | $2.54M |
| 2025-09-30 | $2.40M |
| 2025-06-30 | $2.02M |
| 2025-03-31 | $1.92M |
| 2024-12-31 | $2.16M |
| 2024-09-30 | $2.48M |
| 2024-06-30 | $2.37M |
| 2024-03-31 | $2.57M |
| 2023-12-31 | $2.70M |
| 2023-09-30 | $2.42M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.